Gilead

Latest 20 November 2020

WHO advises against Gilead’s remdesivir for all hospitalised COVID-19 patients

Gilead's remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for…

16 October 2020

Gilead questions WHO study that cast doubts on drug’s COVID-19 benefits

12 July 2020

CiNext – Gilead gives glimpse into feverish drug market

Cyber Security · 9 May 2020 Iran-linked hackers recently targeted coronavirus drugmaker Gilead Hackers linked to Iran have targeted staff at U.S. drugmaker Gilead Sciences Inc in recent weeks, according to publicly-available web archives reviewed…

Coronavirus · 24 Apr 2020 Gilead disputes report that its drug flopped in leaked coronavirus trial A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China,…